Great to strengthen the bond of collaboration and exploit synergies between R&D initiatives, clinicians and researchers from our sister projects @HDMFUN and HAP2 which present and discuss their findings at the International Symposium on Immunotherapy of Severe Infections. #sepsis
If you are a hospital-based physician or a physician in training in the EU, please take this survey to help @immunosep investigators learn more about your impressions of immunotherapy for sepsis patients. https://t.co/tYa06Ic4tp
Dr. Evangelos Giamarellos-Bourboulis giving us the update on the recently completed @immunosep trial… results expected fall 2024- comparing immunotherapy (MALS: anakinra or Immunoparalysis: interferon-gamma) vs std of care in patients with sepsis. A huge accomplishment!
Excited to be in Greece this week with research collaborators to discuss Immunotherapy of Infectious Diseases, with 3 major trials in Sepsis @Immunosep, HAP, and Candidemia with @HdmFun supported by @HorizonEU.
Professoressa Luigina Romani top female scientists in the world https://t.co/EfZ7IyVlH8
👉👉👉Complete ranking for Italy: https://t.co/v3tOBfVPM6
Complete world ranking: https://t.co/XN1M6gSdIJ
👏Congratulations from @HdmFun#unipg@EU_HaDEA